Matsushita Kensuke, Marchandot Benjamin, Jesel Laurence, Ohlmann Patrick, Morel Olivier
Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, 67091 Strasbourg, France.
UMR1260 INSERM, Nanomédecine Régénérative, Faculté de Pharmacie, Université de Strasbourg, F-67401 Illkirch, France.
J Clin Med. 2020 May 9;9(5):1407. doi: 10.3390/jcm9051407.
The recent outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has been declared a public health emergency of international concern. COVID-19 may present as acute respiratory distress syndrome in severe cases, and patients with pre-existing cardiovascular comorbidities are reported to be the most vulnerable. Notably, acute myocardial injury, determined by elevated high-sensitivity troponin levels, is commonly observed in severe cases, and is strongly associated with mortality. Therefore, understanding the effects of COVID-19 on the cardiovascular system is essential for providing comprehensive medical care for critically ill patients. In this review, we summarize the rapidly evolving data and highlight the cardiovascular considerations related to COVID-19.
由严重急性呼吸综合征冠状病毒2引起的2019冠状病毒病（COVID-19）近期爆发已被宣布为国际关注的突发公共卫生事件。COVID-19在重症病例中可能表现为急性呼吸窘迫综合征，据报道，已有心血管合并症的患者最为脆弱。值得注意的是，在重症病例中常见由高敏肌钙蛋白水平升高所确定的急性心肌损伤，且其与死亡率密切相关。因此，了解COVID-19对心血管系统的影响对于为重症患者提供全面医疗护理至关重要。在本综述中，我们总结了快速演变的数据，并强调了与COVID-19相关的心血管方面的考量。
